Success story | Portfolio consolidation and governance in the pharmaceutical industry
Portfolio consolidation and governance in the pharmaceutical industry
CHALLENGES
Our client, a pharmaceutical company, faced difficulties to reach its objectives of new product launch and product changes delivery. These difficulties were partly due to the lack of portfolio management, in a context of high volume of projects and limited resources.
CYLAD was mandated to :
- Consolidate, characterize and rationalize the portfolio of all ongoing and future projects
- Develop an optimized portfolio management system
SOLUTIONS
For the portfolio consolidation, CYLAD :
- structured the portfolio architecture based on project triggers and types
- defined the attributes necessary to facilitate selection and prioritization (e.g. value, risk)
- consolidated all ongoing or forecasted projects within the organization, in a robust shared baseline
Simultaneously, CYLAD defined the portfolio management system:
- Definition and sizing of the organization around newly created Portfolio Manager position, with clear roles and responsibilities
- Demand management & steering processes, methods, routines and rules for portfolio governance, including project in-flow, monitoring, workload/capacity management and arbitration.
KEY DELIVERABLES
- Optimized consolidated portfolio baseline
- Evaluation matrix
- Portfolio management handbook
CUSTOMER BENEFITS
- SHARED SINGLE SOURCE OF TRUTH : Exhaustive project list/portfolio baseline
- PRIORIZATION RULES FOR RESOURCE ALLOCATION of portfolio pipeline based on value/effort analysis
- TEAMS ENGAGED thanks to clear organization and management system
